Rigg, A <br/><br/>
A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas.  [electronic resource] 

 -  British journal of cancer  1997 
 - 101-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1997.16  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow--drug effects<br/>Carboplatin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Gastrointestinal Neoplasms--drug therapy<br/>Humans<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasms, Unknown Primary--drug therapy<br/>Pancreatic Neoplasms--drug therapy<br/>Quality of Life<br/>Survival Rate<br/>Treatment Outcome